Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Haemophilia Treatment Market: By Disease Type: Haemophilia A, Haemophilia B, Von Willebrand Disease, Others; By Product Type; By Therapy; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Haemophilia Treatment Market Outlook

The global haemophilia treatment market is projected to grow at a CAGR of 5% between 2021 and 2026.

 

Global Haemophilia Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Advancements in Technology in Health Care Industry to Propel the Market Growth

The global haemophilia treatment industry is growing due to the increasing prevalence of bleeding disorders and their increasing severity, which has led to the advancement of medical expertise and the increasing amount of clinical research activities in haemophilia. In addition, owing to certain factors, such as the growing use of haemophilia prophylactic medication, the discovery of novel coagulating factors, scientific innovations, the booming biotechnology industry, increasing people's understanding, and increasing research and development focused on finding curative agents, the global demand for haemophilia treatment is thriving. Region-wise, North America led the industry in recent years and contributed a significant market share. Some of the drivers of regional development are expected to be the increasing prevalence of the disease and the propensity towards prophylaxis therapy. In the United States, at a very early age, people are afflicted with this condition.

 

Haemophilia Treatment: Industry Definition and Segmentation

Haemophilia is a hereditary genetic disease that impairs the capacity of the body to regulate coagulation or blood clotting. In this disorder, bleeding from a damaged artery is poorly regulated by clotting factors; thus, coagulation does not occur.

 

Global Haemophilia Treatment Market By Product Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By disease type, the market is divided into:

  • Haemophilia A
  • Haemophilia B
  • Von Willebrand Disease
  • Others

Based on product type, the market segmented into:

  • Recombinant Factor Concentrate
  • Plasma-derived Factor Concentrate
  • Desmopressin
  • Antifibrinolytics
  • Others

Based on therapy, the market segmented into:

  • Replacement Therapy
  • Gene Therapy
  • Immune Tolerance Induction Therapy
  • Others

Based on end-use, the market segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Haemophilia Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Government Initiatives to Augment the Industry Growth of Haemophilia Treatment

The rise in several government policies would increase the industry's growth over the forecast period. Organizations such as the World Haemophilia Organization and governments in several countries perform education and diagnostic services. Government efforts to improve public health and treat vulnerable patients will fuel the market growth for haemophilia treatment in the near term. However, one of the main factors impeding progress would be the high cost of haemophilia medications. High investment, R&D, drug manufacturing and sales by manufacturers are factors resulting in the high cost of the drugs. For families in the middle- and lower-income classes, high retail prices are unaffordable, thereby restricting business growth.

 

Key Industry Players in the Global Haemophilia Treatment Market

The report gives a detailed analysis of the following key players in the global haemophilia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Grifols SA
  • F. Hoffmann-La Roche Ltd
  • Pfizer, Inc.
  • Baxter International, Inc.
  • Bayer AG
  • SANOFI
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Haemophilia Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Haemophilia Treatment Historical Market (2016-2020) 
    8.3    Global Haemophilia Treatment Market Forecast (2021-2026)
    8.4    Global Haemophilia Treatment Market by Disease Type
        8.4.1    Haemophilia A
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Haemophilia B
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Von Willebrand Disease
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Others
    8.5    Global Haemophilia Treatment Market by Product Type
        8.5.1    Recombinant Factor Concentrate
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Plasma-derived Factor Concentrate
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Desmopressin
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Antifibrinolytics
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Others
    8.6    Global Haemophilia Treatment Market by Therapy
        8.6.1    Replacement Therapy
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Gene Therapy
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Immune Tolerance Induction Therapy
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Others
    8.7    Global Haemophilia Treatment Market by End Use
        8.7.1    Hospital Pharmacy
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Retail Pharmacy
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Others
    8.8    Global Haemophilia Treatment Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Grifols SA
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    F. Hoffmann-La Roche Ltd
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Pfizer, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Baxter International, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Bayer AG
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    SANOFI
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Haemophilia Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Haemophilia Treatment Historical Market: Breakup by Disease Type (USD Billion), 2016-2020
3.    Global Haemophilia Treatment Market Forecast: Breakup by Disease Type (USD Billion), 2021-2026
4.    Global Haemophilia Treatment Historical Market: Breakup by Product Type (USD Billion), 2016-2020
5.    Global Haemophilia Treatment Market Forecast: Breakup by Product Type (USD Billion), 2021-2026
6.    Global Haemophilia Treatment Historical Market: Breakup by Therapy (USD Billion), 2016-2020
7.    Global Haemophilia Treatment Market Forecast: Breakup by Therapy (USD Billion), 2021-2026
8.    Global Haemophilia Treatment Historical Market: Breakup by End Use (USD Billion), 2016-2020
9.    Global Haemophilia Treatment Market Forecast: Breakup by End Use (USD Billion), 2021-2026
10.    Global Haemophilia Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global Haemophilia Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America Haemophilia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America Haemophilia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe Haemophilia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe Haemophilia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific Haemophilia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific Haemophilia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America Haemophilia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America Haemophilia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa Haemophilia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa Haemophilia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Global Haemophilia Treatment Market Structure

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Anti-Snoring Treatment Market Report and Forecast 2021-2026



Global Tinea Corporis Treatment Market Report and Forecast 2021-2026


Global Xerostomia Treatment Market Report and Forecast 2021-2026



NEWSLETTER